SINGLEJECT
Live / Registered — Registered and renewed (as of 07 Jul 2020)
What this means for you
Registered since 01 Aug 2000. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Aug 2020).
Record
- Serial number
- 74663645
- Registration number
- 2373083
- Mark type
- Word mark
- Filed
- 20 Apr 1995
- Published for opposition
- 28 Jan 1997
- Registered
- 01 Aug 2000
- Next maintenance due
- 01 Aug 2020
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation sold in prefilled syringes for use in connection with one or more of the following - the treatment of viral, neoplastic and autoimmune diseases; treatment of neurological disorders; for stimulating white blood cell production; for stimulating red blood cell production; and for increasing platelet count
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Apr 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jul 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 Jul 2020 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 07 Jul 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Jul 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL